OPRX NASDAQ
OptimizeRx Corp.
1W: +1.5%
1M: +16.0%
3M: +42.2%
YTD: -27.1%
1Y: -58.2%
3Y: +9.6%
5Y: -89.8%
$9.06
-0.01 (-0.11%)
Weekly Expected Move ±7.1%
$8
$9
$9
$10
$10
Credit Risk of going bust: higher than 62% of companies Debt: 10.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.15 (down 98%), OptimizeRx Corp. would be worth roughly what it owes.
Total debt $19.5M against a stock market value of $170.7M.
Distance to default 4.05 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $10.1M (short-term plus half of long-term), stock volatility 70.5%; Altman Z'' 4.79. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.15 (down 98%), OptimizeRx Corp. would be worth roughly what it owes.
Total debt $19.5M against a stock market value of $170.7M.
Distance to default 4.05 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $10.1M (short-term plus half of long-term), stock volatility 70.5%; Altman Z'' 4.79. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2023-10-16
Earliest Filing
2023-10-25
Latest Filing
target: 3
Counterparties (Filed by OPRX)
3 relationshipsCompanies named in OPRX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Healthy Offers, Inc. | — | target | Target company acquired in a merger agreement | 2023-10-25 | View |
| Medicx Health | — | target | Doing business as name of the target company acquired in a merger | 2023-10-25 | View |
| Healthy Offers, Inc. | — | target | Target company in the Merger Agreement, operating as Medicx Health. | 2023-10-16 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-12 | Earnings Release; Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-06-12 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-06-05 | Officer/Director Change | View | |
| 2026-05-12 | Material Agreement; Termination of Agreement; Earnings Release; Financial Obligation; Exhibits | Agreement | View |
| 2026-04-09 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-03-30 | Accountant Change; Exhibits | View | |
| 2026-03-05 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Other Event | Agreement | View |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-19 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-24 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-06-16 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-18 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-03-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-10 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-01-10 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2024-12-23 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2024-11-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-08-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR